Which has the lower trailing P/E, CHE or DOCS?

CHE has the lower trailing P/E: CHE trades at 26.12 and DOCS at 30.11. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CHE or DOCS?

Over the past five years, DOCS grew revenue faster — CHE at a 4.12% CAGR versus DOCS at 21.94%.

Does CHE or DOCS pay a bigger dividend?

CHE pays a dividend (0.48% yield), while DOCS has no payments in the available dividend history.

Is CHE or DOCS more profitable?

DOCS runs the higher net margin — CHE at 10.60% versus DOCS at 25.48%.

How have CHE and DOCS total returns compared?

Over the past 5 years, CHE delivered 15.15% and DOCS delivered -20.88% annualized total return. Past performance doesn't predict future results.

Chemed Corporation (CHE) vs Doximity, Inc. (DOCS)

A side-by-side comparison of Chemed Corporation and Doximity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

CHE

Chemed Corporation

$6.80B

$520.27HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

DOCS

Doximity, Inc.

$4.79B

$25.59HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — CHE vs DOCS

growth of $100 · dividends reinvested · last 5y

CHE +12.6% (+2.4%/yr)DOCS -51.7% (-13.6%/yr)CHE compounded faster over this window

CHE DOCS

CHE vs DOCS: by the numbers

•CHE is the larger company ($6.80B vs $4.79B market cap).
•CHE trades at the lower trailing earnings multiple (26.12 vs 30.11 P/E), one valuation lens rather than an overall verdict.
•DOCS converts more revenue to profit (25.48% vs 10.60% net margin).
•DOCS grew revenue faster over the past five years (21.94% vs 4.12% CAGR).
•CHE pays a dividend (0.48% yield), while DOCS has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CHE	DOCS
P/E ratio	26.12	30.11
Forward P/E	20.38	16.55
P/S ratio	2.69	7.46
P/B ratio	8.41	5.34
EV / EBITDA	17.50	21.87
FCF yield	4.63%	6.12%

Profitability

Metric	CHE	DOCS
Gross margin	30.44%	88.07%
Operating margin	13.46%	29.60%
Net margin	10.60%	25.48%
ROE	33.11%	18.24%
ROIC	19.48%	15.35%

Dividends

Metric	CHE	DOCS
Dividend yield	0.48%	N/A
Payout ratio	13.57%	N/A

Growth (annualized)

Metric	CHE	DOCS
Revenue CAGR (5Y)	4.12%	21.94%
EPS CAGR (5Y)	-1.65%	54.32%
FCF CAGR (5Y)	-5.44%	23.75%
Total return CAGR (5Y)	2.27%	-20.88%

Frequently asked

Which has the lower trailing P/E, CHE or DOCS?: CHE has the lower trailing P/E: CHE trades at 26.12 and DOCS at 30.11. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CHE or DOCS?: Over the past five years, DOCS grew revenue faster — CHE at a 4.12% CAGR versus DOCS at 21.94%.
Does CHE or DOCS pay a bigger dividend?: CHE pays a dividend (0.48% yield), while DOCS has no payments in the available dividend history.
Is CHE or DOCS more profitable?: DOCS runs the higher net margin — CHE at 10.60% versus DOCS at 25.48%.
How have CHE and DOCS total returns compared?: Over the past 5 years, CHE delivered 15.15% and DOCS delivered -20.88% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CHE analysis Full DOCS analysis Interactive comparison tool

Dig into the metrics

Chemed P/E ratio Doximity P/E ratio Chemed dividend yield Chemed ROE Doximity ROE Chemed operating margin Doximity operating margin Chemed revenue growth Doximity revenue growth Chemed free cash flow Doximity free cash flow

Chemed & Doximity appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.